Pol-e Khumri, Baglan May 31, 2026 (Issuewire.com) - Opening: Why This Research Matters
A new scientific review sheds light on how transdermal patches—small adhesive systems that deliver drugs through the skin—are rapidly evolving into one of the most promising drug delivery technologies in modern medicine. Published in the Asian Journal of Research in Medical and Pharmaceutical Sciences (2025), the study examines how these patches are moving beyond traditional uses such as nicotine and pain relief into advanced applications, including smart insulin delivery, biodegradable microneedles, and 3D-printed personalized therapies.
The findings highlight a major shift in pharmaceutical science: instead of relying solely on oral tablets or injections, researchers are increasingly developing skin-based systems that provide controlled, long-acting, and patient-friendly drug delivery. This transformation has the potential to improve treatment adherence, reduce side effects, and expand access to advanced therapies for chronic and complex diseases.
Background: The Challenge of Traditional Drug Delivery
Conventional drug delivery methods such as oral tablets and injections come with well-known limitations. Oral drugs often lose effectiveness because they are broken down in the digestive system and liver before reaching the bloodstream—a process known as first-pass metabolism. Injections, while effective, can be painful, inconvenient, and increase the risk of infection.
Transdermal patches offer an alternative approach by delivering drugs directly through the skin and into systemic circulation. The skin acts as both a barrier and a gateway, allowing only suitable drug molecules to pass through. Because of this, transdermal systems are especially useful for long-term treatments such as pain management, hormone therapy, smoking cessation, and cardiovascular care.
However, early patch systems were limited by issues such as poor skin penetration, restricted drug types, and variability in absorption. The review emphasizes how ongoing research is addressing these limitations through advanced materials and engineering techniques.
Key Findings of the Study
- Transdermal Patches Offer Controlled and Continuous Drug Delivery
The review confirms that one of the biggest advantages of transdermal systems is their ability to release drugs slowly over hours or even days. This ensures stable drug levels in the bloodstream, reducing the risk of overdose or missed doses and improving therapeutic outcomes.
- Multiple Patch Designs Enable Different Drug Release Mechanisms
Researchers categorize transdermal patches into four main types:
- Drug-in-adhesive systems—simple, cost-effective designs where the drug is embedded in the adhesive layer
- Reservoir systems—drugs stored in a separate compartment with controlled release membranes
- Matrix systems – drugs dispersed within a polymer structure
- Micro-reservoir systems – hybrid systems combining matrix and reservoir technologies
Each design offers different levels of control, safety, and drug-loading capacity.
- Microneedle Patches Expand Drug Possibilities
One of the most significant advances highlighted is the development of microneedle-based patches. These contain microscopic needles that painlessly penetrate the skin barrier and deliver drugs more effectively.
Microneedles come in several forms:
- Solid
- Hollow
- Coated
- Dissolving (biodegradable)
These systems allow delivery of larger molecules such as vaccines, insulin, and biologics—drugs that previously could not be administered through the skin.
- Smart Patches Enable Real-Time Monitoring and Responsive Therapy
A major innovation discussed is the emergence of “smart patches.” These devices integrate sensors and responsive materials that can detect biological signals such as glucose levels, pH changes, or wound conditions.
For example, glucose-responsive patches can automatically release insulin when blood sugar levels rise, offering a potential breakthrough for diabetes management. Other smart systems can monitor wound healing and adjust drug release accordingly.
- Biodegradable and Dissolving Patches Improve Safety and Sustainability
The study highlights dissolving microneedle patches made from biodegradable materials that safely break down in the skin after drug delivery. These eliminate the need for removal and reduce medical waste.
Such systems have been tested for antibiotics, vaccines, and insulin delivery, showing promising results in preclinical studies.
- 3D Printing Enables Personalized Medicine
Another key advancement is the use of 3D printing to design customized transdermal patches. This allows researchers to tailor patch size, drug dosage, and release rate according to individual patient needs.
3D-printed microneedles and hydrogel-based patches have shown strong potential in wound healing, vaccine delivery, and dermatological treatments.
- High-Loading Patches Improve Long-Term Therapy
Innovations in polymer chemistry now allow higher drug loading and more controlled release profiles. This is particularly important for chronic diseases that require long-term medication, such as hypertension, cancer, and neurological disorders.
Significance and Real-World Impact
The findings of this review underline a major shift in pharmaceutical technology toward non-invasive, patient-centered drug delivery systems. Transdermal patches are no longer limited to simple pain relief or hormone therapy—they are evolving into multifunctional platforms capable of the following:
- Delivering complex biologic drugs
- Enabling self-regulated insulin therapy
- Supporting vaccine administration without injections
- Monitoring wound healing in real time
- Providing personalized treatment through 3D printing
If widely adopted, these innovations could reduce hospital visits, improve medication adherence, and make chronic disease management more convenient and effective.
From a healthcare perspective, this technology may also help address global challenges such as needle anxiety, poor treatment compliance, and limited access to healthcare infrastructure in remote regions.
Methodology: How the Study Was Conducted
This research is a comprehensive literature review. The authors systematically analyzed previously published studies, clinical trials, and experimental research related to transdermal drug delivery systems.
The review focuses on:
- Skin physiology and drug penetration mechanisms
- Types and structures of transdermal patches
- Advances in microneedle technology
- Smart and responsive drug delivery systems
- Manufacturing techniques such as solvent casting, extrusion, and 3D printing
- Clinical applications across multiple disease areas
By synthesizing findings from diverse studies, the authors provide an updated overview of current technologies, limitations, and future directions in the field.
Conclusion: A Promising Future for Skin-Based Drug Delivery
Transdermal patch technology is entering a new era driven by innovation in materials science, nanotechnology, and biomedical engineering. While traditional patches already offer clear advantages over oral and injectable drugs, emerging systems such as smart patches, dissolving microneedles, and 3D-printed devices are expanding the boundaries of what is medically possible.
However, challenges remain. Skin irritation, limited drug permeability, and variability between patients continue to affect performance. The review emphasizes that ongoing research must focus on improving safety, increasing drug compatibility, and ensuring consistent delivery across different patient populations.
Despite these challenges, the future of transdermal drug delivery appears highly promising. With continued innovation, these systems may soon become a central pillar of personalized, non-invasive medicine.
About the Study / Institution
The review was conducted by researchers from the School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences and Technology, India. The work reflects ongoing academic efforts to advance pharmaceutical sciences and develop innovative drug delivery systems that improve patient care and treatment efficiency.
References
Mishra, R., Verma, A., Sharma, B., & Sharma, P. (2025). An Overview of Transdermal Patches: Opportunities and Obstacles in Modern Drug Delivery. Asian Journal of Research in Medical and Pharmaceutical Sciences, 14(3), 18–29. https://doi.org/10.9734/ajrimps/2025/v14i3314
Wong, W. F., Ang, K. P., Sethi, G., & Looi, C. Y. (2023). Recent Advancement of Medical Patches for Transdermal Drug Delivery. Medicina (Kaunas, Lithuania), 59(4), 778. https://doi.org/10.3390/medicina59040778
Media Contact
AJRIMPS km1046388@gmail.com https://journalajrimps.com
